Modelling hepatitis C virus infection and the development of hepatocellular carcinoma
被引:7
|
作者:
Chakrabarty, Siddhartha P.
论文数: 0引用数: 0
h-index: 0
机构:
Indian Inst Technol Guwahati, Dept Math, Gauhati 781039, Assam, IndiaIndian Inst Technol Guwahati, Dept Math, Gauhati 781039, Assam, India
Chakrabarty, Siddhartha P.
[1
]
Murray, John M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia
Univ New S Wales, Kirby Inst, Sydney, NSW 2052, AustraliaIndian Inst Technol Guwahati, Dept Math, Gauhati 781039, Assam, India
Murray, John M.
[2
,3
]
机构:
[1] Indian Inst Technol Guwahati, Dept Math, Gauhati 781039, Assam, India
[2] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia
[3] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia
While mathematical models exist describing the dynamics of hepatitis C virus (HCV), most of them focus on the short term dynamics after the commencement of antiviral therapy. This work is the first attempt at mathematically modelling the full course of HCV infection and the impact that these viral and immune processes have on the progression to hepatocellular carcinoma (HCC). This model is based on the premise that these long term conditions are ultimately random and likely driven by the cell-mediated immune response. The risk of cancer arising is modelled through a stochastic model that incorporates the dynamics of HCV over the course of infection. Our model simulations produce approximately 9% prevalence of HCC in individuals after 40 years, consistent with the literature estimates. We find that higher viral infectivity leads to a greater likelihood of developing HCC (p <0.0001), but it does not determine the speed with which it arises. This infectivity drives the level of immune response, the amount of hepatocyte proliferation, and the risk of a mutational event. In our simulations the probability of developing HCC increases approximately linearly with duration of infection at the rate of 2.4 incident cases per thousand HCV-infected person years. This indicates that the sooner viral replication can be suppressed through antiviral therapy, the greater the chance of forestalling HCC. (C) 2012 Elsevier Ltd. All rights reserved.
机构:
Hosp Univ Penn, Philadelphia, PA 19104 USA
Wroclaw Med Univ, Dept Gastroenterol & Hepatol, PL-50556 Wroclaw, PolandHosp Univ Penn, Philadelphia, PA 19104 USA
Blonski, Wojciech
Reddy, K. Rajender
论文数: 0引用数: 0
h-index: 0
机构:
Hosp Univ Penn, Philadelphia, PA 19104 USAHosp Univ Penn, Philadelphia, PA 19104 USA
机构:
Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, JapanHiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan
Ohishi, W
Kitamoto, M
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, JapanHiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan
Kitamoto, M
Aikata, H
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, JapanHiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan
Aikata, H
Kamada, K
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, JapanHiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan
Kamada, K
Kawakami, Y
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, JapanHiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan
Kawakami, Y
Ishihara, H
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, JapanHiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan
Ishihara, H
Kamiyasu, M
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, JapanHiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan
Kamiyasu, M
Nakanishi, T
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, JapanHiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan
Nakanishi, T
Tazuma, S
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, JapanHiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan
Tazuma, S
Chayama, K
论文数: 0引用数: 0
h-index: 0
机构:
Hiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, JapanHiroshima Univ, Dept Med & Mol Sci, Div Frontier Med Sci, Programs Biomed Res,Grad Sch Biomed Sci,Minami Ku, Hiroshima 7348551, Japan